<DOC>
<DOCNO>EP-0619819</DOCNO> 
<TEXT>
<INVENTION-TITLE>
1-ARYLHETEROARYLALKYL SUBSTITUTED-1H-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS
</INVENTION-TITLE>
<CLASSIFICATIONS>A61P912	C07D52100	C07D40114	C07D40106	A61P900	A61K314439	A61P904	A61K3144	A61P908	A61K314427	A61K314427	C07D40110	A61P900	C07D52100	A61P910	A61K3144	C07D40100	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61P	C07D	C07D	C07D	A61P	A61K	A61P	A61K	A61P	A61K	A61K	C07D	A61P	C07D	A61P	A61K	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61P9	C07D521	C07D401	C07D401	A61P9	A61K31	A61P9	A61K31	A61P9	A61K31	A61K31	C07D401	A61P9	C07D521	A61P9	A61K31	C07D401	</CLASSIFICATIONS-FOURTH>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<DESCRIPTION>
Non-peptidic 1-arylheteroarylalkyl substituted-1H-1,2,4-triazole 
compounds are described for use in 
treatment of circulatory disorders such as hypertension and 
congestive heart failure. Of particular interest are 
angiotensin II antagonist compounds provided by 1H-1,2,4-triazoles 
having a arylheteroarylmethyl moiety attached to 
the nitrogen atom at the one-position of the 1H-1,2,4-triazole. The renin-angiotensin system is one of the 
hormonal mechanisms involved in regulation of 
pressure/volume homeostasis and in expression of 
hypertension. Activation of the renin-angiotensin cascade 
begins with renin secretion from the juxtaglomerular 
apparatus of the kidney and culminates in the formation of 
angiotensin II, the primary active species of this system. 
This octapeptide, angiotensin II, is a potent 
vasoconstrictor agent and also produces other physiological 
effects such as promoting aldosterone secretion, promoting 
sodium and fluid retention, inhibiting renin secretion, 
increasing sympathetic nervous system activity, increasing 
vasopressin secretion, causing positive cardiac inotropic 
effect and modulating other hormonal systems. Previous studies have shown that antagonizing 
angiotensin II at its receptors is a viable approach to  
 
inhibit the renin-angiotensin system, given the pivotal 
role of this octapeptide which mediates the actions of the 
renin-angiotensin system through interaction with various 
tissue receptors. There are several known angiotensin II 
antagonists, most of which are peptidic in nature. Such 
peptidic compounds are of limited use due to their lack of 
oral bioavailability or their short duration of action. 
Also, commercially-available peptidic angiotensin II 
antagonists (e.g., Saralasin) have a significant residual 
agonist activity which further limit their therapeutic 
application. Non-peptidic compounds with angiotensin II 
antagonist properties are known. For example, the sodium 
salt of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic 
acid has specific competitive angiotensin II 
antagonist activity as shown in a series of binding 
experiments, functional assays and in vivo tests [P. C. 
Wong et al, J. Pharmacol. Exp. Ther., 247 (1), 1-7 (1988)]. 
Also, the sodium salt of 2-butyl-4-choloro-1-(2-nitrobenzyl)imidazole-5-acetic 
acid has specific 
competitive angiotensin II antagonist activity as shown in 
a series of binding experiments, functional assays and in 
vivo tests [A. T. Chiu et al, European J. Pharmacol., 157, 
3121 (1988)]. A family of
</DESCRIPTION>
<CLAIMS>
Claims for the following Contracting States : AT, BE, CH, LI, DE, DK,FR 
GB, IT, LU, NL, SE
A compound selected from a family 
of compounds of Formula II 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 
3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
sec-butyl, isobutyl, 4-methylbutyl, ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 
2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

  
 

or a tautomer thereof or a pharmaceutically-acceptable salt 
thereof. 
A compound of Claim 1 selected from compounds 
and their pharmaceutically-acceptable salts of the group of 

compounds consisting of 

2-[6-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid;  
 
2-[6-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
5-[2-[6-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl) methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole;  

 
5-[2-[6-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[[3-(2-cyclohexylethyl)-5-butyl-1H,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
and 
5-[2-[6-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula III 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 

benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 
N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 

2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 
R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl,  
 

1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 
1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 

1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 
-cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 

2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 
2,6-difluorophenyl, 1-butenyl, 2-butenyl, 

3-butenyl, 1-butynyl, 2-butynyl, 3-butynyl, propylthio and 
butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and 


 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof. 
A compound of Claim 3 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3,5-dipropyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(1,1-difluorobutyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[(3-neopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-butyl-5-neopentyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-ethylbutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
5-[2-[5-[[3-butyl-5-(2-ethylbutyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-phenylethyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(N-methyl-N-tertbutylamido)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(N-methyl-N-tertbutylamido)-1H-1,2,4-triazol-1-yl]methyl)-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(N-methylamido)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(N-methylamido)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-butyl-5-phenyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-methylphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-methylphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-isopropylphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-isopropylphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-methoxyphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-methoxyphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-chlorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-chlorophenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2,6-difluorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2,6-difluorophenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
2-[5-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl) methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl)-2-pyridinyl]benzoic 

acid; 
2-[5-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid;  
 
2-[5-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
5-[2-[5-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
5-[2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
and 
5-[2-[5-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula IV 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 
2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 
1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 

cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 

2,6-difluorophenyl, 1-butenyl, 2-butenyl, 3-butenyl, 
1-butynyl, 2-butynyl, 3-butynyl, propylthio and 

butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and  

 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof. 
A compound of Claim 5 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

2-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid;  

 
2-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
5-[2-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole;  

 
5-[2-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
and 
5-[2-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula V 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 
2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl,  
 

1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 
1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 

1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 
cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 

2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 
2,6-difluorophenyl, 1-butenyl, 2-butenyl, 3-butenyl, 

1-butynyl, 2-butynyl, 3-butynyl, propylthio and 
butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and 


 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof. 
A compound of Claim 7 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid;  

 
3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
5-[3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole;  

 
5-[3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
and 
5-[3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula VI 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl,  
 

neopentyl, phenyl, benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, 
N-methylamido, N-methyl-N-tertbutylamido, 

2-methylphenyl, 2-isopropylphenyl, 2-methoxyphenyl, 
2-chlorophenyl, 2,6-difluorophenyl, cyclohexyl, 

cyclohexylmethyl, 2-butenyl, 3-butenyl, 2-butynyl, 
3-butynyl and 2-hydroxybutyl; wherein R
2
 is selected from 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

4-methylbutyl, n-pentyl, 1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 
1,1-difluoro-2-phenylethyl, 1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 
1,1-dimethoxybutyl, 1,1-difluoroethyl, 

1,1-difluoropropyl, 1,1-difluorobutyl, 1,1-difluoropentyl, 
phenyl, benzyl, 2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

 
or a tautomer thereof or a p
harmaceutically-acceptable salt 
thereof. 
A compound of Claim 9 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

4-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid;  

 
4-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
5-[4-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole;  

 
5-[4-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
and 
5-[4-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl] 

methyl]phenyl]
-3-pyridinyl]-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula VII 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, 

N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 
3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 
2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof.  
 
A compound of Claim 11 selected-from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid;  
 
3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-dif1uorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
5-[3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl] 

phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole;  
 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
and 
5-[3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole. 
Compound of Claim 2 which is 5-[2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl-1H-tetrazole 
or a pharmaceutically-acceptable 

salt thereof. 
Compound of Claim 4 which is 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole 
or a pharmaceutically-acceptable salt thereof. 
Compound of Claim 4 which is 
5-[2-[5-[[3-butyl-5-(N-methyl-N-tertbutylamido)-1H-1,2,4-triazol-1-yl]
methyl]-2-pyridinyl]
phenyl]-1H-tetrazole 

or a pharmaceutically-acceptable salt thereof. 
Compound of Claim 12 which is 
5-[2-[5-[[3-(2-chlorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]
methyl]-2-pyridinyl]
phenyl]-1H-tetrazole 

or a pharmaceutically-acceptable salt thereof. 
A pharmaceutical composition comprising a 
therapeutically-effective amount of an angiotensin II 

antagonist compound and a pharmaceutically-acceptable  
 

carrier or diluent, said antagonist compound selected from a 
family of compounds according to any of Claims 1-16. 
Use of a compound according to any of Claims 1-16 
for preparing a medicament for treating a circulatory disorder. 
Use according to Claim 18 wherein said circulatory 
disorder is a cardiovascular disorder. 
Use according to Claim 19 wherein said cardiovascular 
disorder is hypertension. 
Use according to Claim 19 wherein said cardiovascular 
disorder is congestive heart failure. 
Claims for the following Contracting State : ES
A process for preparing a compound selected from a 
family of compounds of formula II 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 
3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
sec-butyl, isobutyl, 4-methylbutyl, ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 
2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

  
 

or a tautomer thereof or a pharmaceutically-acceptable salt 
thereof, characterized in that a triazole of the formula 1 


 
wherein R
1
, R
2
 are 
as defined above 

is reacted in the presence of a base with a compound 8 

 
and subequently coupled with a compound 7 of the formula 


 
via the Snieckus coupling reaction which can be transformed in 

a known manner into the compounds wherein R is COOH
 
or a compound 17 of the formula 


 
is reacted with the compound 8, subsequently with an 

appropriate orthoester and then coupled with a compound 7 via 
the above Sniekus reaction
 
thus giving the desired final compounds or tautomers thereof 

which optionally may be transformed in a known manner into  
 

compounds wherein R
5
 is COOH or tetrazole and/or the 
respective pharmaceutically-acceptable salts thereof. 
A process according to Claim 1 wherein the compound 
prepared is seleced from compounds and their pharmaceutically-acceptable 

salts of the group of compounds consisting of 

2-[6-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isopropyl-3-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyi]
benzoic 
acid; 
2-[6-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid;  
 
2-[6-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1,1-difLuorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
5-[2-[6-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole;  

 
5-[2-[6-[(3-phenyl-5-butyl-LH-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl] 

methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
and 
5-[2-[6-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole. 
A process for preparing a compound selected from a 
family of compounds of Formula III 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 
2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl,  
 

1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 
1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 

1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 
cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 

2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 
2,6-difluorophenyl, 1-butenyl, 2-butenyl, 

3-butenyl, 1-butynyl, 2-butynyl, 3-butynyl, propylthio and 
butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and 


 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof, characterized in that the triazole of the formula 1 

 
wherein R
1
, R
2
 are as indicated above, is reacted in the 
presence of a base with a compound 10 of the formula 


 
or a compound of the formula 17 


  
 

is reacted with a compound of the formula 10 and subsequently 
treated with an appropriate orthoester,
 
and the thus resulting compound is then reacted with a 

compound of the formula 7 

 
via the Snieckus coupling reaction
 
thus yielding the desired final compounds and tautomers 

thereof which optionally may be transformed in a knownn manner 
into compounds wherein R
5
 is COOH or tretrazole and/or the 
respective ph
armaceutically-acceptable salts. 
A process according to Claim 3 wherein the compound 
prepared is selected from compounds and their pharmaceutically-acceptable 

salts of the group of compounds consisting of 

2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3,5-dipropyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(1,1-difluorobutyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[(3-neopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-butyl-5-neopentyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-ethylbutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
5-[2-[5-[[3-butyl-5-(2-ethylbutyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-phenylethyl)-1H-1,2,4-triazol-1-yl] 

methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(N-methyl-N-tertbutylamido)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(N-methyl-N-tertbutylamido)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(N-methylamido)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(N-methylamido)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-butyl-5-phenyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-methylphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-methylphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-isopropylphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-isopropylphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-methoxyphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-methoxyphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-chlorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-chlorophenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2,6-difluorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2, 6-difluorophenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
2-[5-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid;  
 
2-[5-[[3(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
5-[2-[5-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl] 

methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
5-[2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
and 
5-[2-[5-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]
methyl]-2-pyridinyl]
phenyl]-1H-tetrazole. 
A process for preparing a compound selected from a 
family of compounds of formula IV 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 
2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 
1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 

cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 

2,6-difluorophenyl, 1-butenyl, 2-butenyl, 3-butenyl, 
1-butynyl, 2-butynyl, 3-butynyl, propylthio and 

butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and  

 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof, characterized in that a triazole of the formula 1 

 
wherein R
1
, R
2
 are as defined above, is reacted in the 
presence of a base with a compound of the formula 53 


 
or a compound of the formula 28 


 
is reacted with a compound of the formula 30  

 

 
via the Snieckus coupling reaction
 
thus giving the desired final compounds and their tautomers 

which may optionally be transformed in a known manner into 
compounds wherein R
5
 is as indicated and/or their pharmaceutically-acceptable 
salts. 
A process according to Claim 5 wherein the compound 
prepared is selected from compounds and their pharmaceutically-acceptable 

salts of the group of compounds consisting of 

2-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid;  

 
2-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1-oxo-2-phenilethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
5-[2-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole;  

 
5-[2-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]3-pyridinyl]
-1H-tetrazole; 
and 
5-[2-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]3-pyridinyl]
-1H-tetrazole. 
A process for preparing a compound selected from a 
family of compounds of Formula V 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl,  
 

2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 
R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 
1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 

cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 

2,6-difluorophenyl, 1-butenyl, 2-butenyl, 3-butenyl, 
1-butynyl, 2-butynyl, 3-butynyl, propylthio and 

butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and 


 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof, characterized in that, a suitably substituted 
triazole of the formula 1 


 
wherein R
1
, R
2
 are defined as indicated above is, reacted in 
the presence of a base with a compound of the formula 62  

 

 
or a comound of the formula 28 


 
wherein R
1
, R
2
 are defined above, is reacted with a compound 
of the formula 31 


 
via the Snieckus coupling reaction  

 
thus resulting in the desired final compounds and tautomers 

which can optionally be transformed in a known manner into 
compounds wherein R
5
 is as indicated above and/or the pharmaceutically-acceptable 
salts thereof. 
A process according to Claim 7 wherein the compound 
prepared is selected from 


3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid;  

 
3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
5-[3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-(3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole;  

 
5-[3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1,1-difluorobutyll-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
and 
5-[3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole. 
A process for preparing a compound selected from a 
family of compounds of Formula VI 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl,  
 

neopentyl, phenyl, benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, 
N-methylamido, N-methyl-N-tertbutylamido, 

2-methylphenyl, 2-isopropylphenyl, 2-methoxyphenyl, 
2-chlorophenyl, 2,6-difluorophenyl, cyclohexyl, 

cyclohexylmethyl, 2-butenyl, 3-butenyl, 2-butynyl, 

3-butynyl and 2-hydroxybutyl; wherein R
2
 is selected from 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

4-methylbutyl, n-pentyl, 1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 
1,1-difluoro-2-phenylethyl, 1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 
1,1-dimethoxybutyl, 1,1-difluoroethyl, 

1,1-difluoropropyl, 1,1-difluorobutyl, 1,1-difluoropentyl, 
phenyl, benzyl, 2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof, characterized in that a triazole of the formula 1 

 
with R
1
, R
2
 as defined above, is reacted in the presence of a 
base with a compound 69 of the formula  

 

 
or a compound of the formula 28 


 
with R
1
, R
2
 as defined above, is reacted with a compound of 
the formula 29 


 
via the Snieckus coupling reaction
 
thus resulting in the desired final compounds and their tautomer 

which optionally may be transformed in a known manner into 
the compounds wherein R
5
 is COOH, tetrazole and/or the. 
respective pharmaceutically-acceptable salts thereof.  

 
A process according to Claim 9 wherein the compound 
prepared is selected from compounds and their pharmaceutically-acceptable 

salts of the group of compounds consisting of 

4-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyllphenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid;  
 
4-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
5-[4-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl)-1H-tetrazole; 
5-[4-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole;  
 
5-[4-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl] 

methyl] phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
and 
5-[4-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole. 
A process for preparing a compound selected from a 
family of compounds of Formula VII 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, 

N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 
3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyc
lohexylethyl, 
2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 

1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 
1,1-difluoropentyl, phenyl, benzyl, 

2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 
cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 

2-methylphenyl, 2-isopropylphenyl,  
 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof, characterized in that, a suitable substituted 
triazole of the formula 1 


 
wherein R
1
, R
2
 are as described above, is reacted in the 
presence of a base with a compound of the formula 75 


  
 

to give the desired final compounds and tautomers thereof 
wherein R
5
 is COOH which upon derivatisation in a known manner 
can be transformed into compounds wherein R
5
 is tetrazole or a 
pharmaceutically-acceptable salt thereof;
 
or a compound of the formula 28 


 
with R
1
, R
2
 as defined above is reacted with a compound 32 

 
to give the desired final compounds and their tautomers which 

optionally may be transformed in a known manner into compounds 
wherein R
5
 is COOH, tetrazole and/or their pharmaceutically-acceptable 
salts. 
A process according to Claim 11 wherein the compound 
prepared is selected from compounds and their pharmaceutically-acceptable 

salts of the group of compounds consisting of  
 


3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid;. 
3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid;  
 
3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
5-[3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole;  
 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
and 
5-[3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole. 
A process according to Claim 2 wherein the compound 
prepared is 5-[2-[6-[3,5-dibutyl-1H-1,2,4-triazol-1-yl)-methyl]
-3-pyridinyl]phenyl-1H-tetrazole 

or a pharmaceutically-acceptable 
salt thereof. 
A process according to Claim 4 wherein the compound 
prepared is 5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl) 

methyl]-2-pyridinyl]
phenyl]-1H-tetrazole or a pharmaceutically-acceptable 

salt thereof. 
A process according to Claim 4 wherein the compound 
prepared is 5-[2-[5-[(3-butyl-5-(N-methyl-N-tert-butylamido)-1H-1,2,4-triazol-1-yl]
methyl]-2-pyridinyl]
phenyl]-1H-tetrazole 

or a pharmaceutically-acceptable salt thereof. 
A process according to Claim 12 wherein the compound 
prepared is 5-[2-[5-[(3-(2-chlorophenyl)-5-buty
l-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole 
or a 

pharmaceutically-acceptable salt thereof. 
A process for preparing a pharmaceutical composition 
characterized in that a therapeutically-effective amount of an 

angiontensin II antagonist compound and a pharmaceutically-acceptable 
carrier or diluent are admixed said antagonist 

copmound selected from a family of compounds according to any 
of Claim 1-16.  

 
Use of a compound as prepared according to any of 
Claims 1-16 for preparing a medicament for treating a 

circulatory disorder. 
Use according to Claim 18 wherein said circulatory 
disorder is a cardiovascular disorder. 
Use according to Claim 19 wherein said cardiovascular 
disorder is hypertension. 
Use according to Claim 19 wherein said cardiovascular 
disorder is congestive heart failure. 
Claims for the following Contracting State : GR
A compound selected from a family 
of compounds of Formula II 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 
3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 
2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

  
 

or a tautomer thereof or a pharmaceutically-acceptable salt 
thereof. 
A compound of Claim 1 selected from compounds 
and their pharmaceutically-acceptable salts of the group of 

compounds consisting of 

2-[6-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyll-3-pyridinyl]benzoic 

acid; 
2-[6-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazoI-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
benzoic 
acid; 
2-[6-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid;  
 
2-[6-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
2-[6-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]benzoic 

acid; 
5-[2-[6-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole;  

 
5-[2-[6-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[6-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[6-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole; 
and 
5-[2-[6-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-3-pyridinyl]phenyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula III 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 
2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl,  
 

1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 
1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 

1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 
cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 

2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 
2,6-difluorophenyl, 1-butenyl, 2-butenyl, 

3-butenyl, 1-butynyl, 2-butynyl, 3-butynyl, propylthio and 
butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and 


 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof. 
A compound of Claim 3 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3,5-dipropyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(1,1-difluorobutyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[(3-neopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-butyl-5-neopentyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-ethylbutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
5-[2-[5-[[3-butyl-5-(2-ethylbutyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-phenylethyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(N-methyl-N-tertbutylamido)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(N-methyl-N-tertbutylamido)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(N-methylamido)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(N-methylamido)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-butyl-5-phenyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-methylphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-methylphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-isopropylphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-isopropylphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-methoxyphenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-methoxyphenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-chlorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2-chlorophenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2,6-difluorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-butyl-5-(2,6-difluorophenyl)-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
2-[5-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl) methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
benzoic 
acid; 
2-[5-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid;  
 
2-[5-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]benzoic 

acid; 
5-[2-[5-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]-2-pyridinyl]
phenyl]-1H-tetrazole; 
5-[2-[5-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
5-[2-[5-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole;  
 
5-[2-[5-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole; 
and 
5-[2-[5-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula IV 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 
2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 
1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 

cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 

2,6-difluorophenyl, 1-butenyl, 2-butenyl, 3-butenyl, 
1-butynyl, 2-butynyl, 3-butynyl, propylthio and 

butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and  

 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof. 
A compound of Claim 5 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

2-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid;  

 
2-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
2-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
2-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
5-[2-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole;  

 
5-[2-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[2-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[2-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
and 
5-[2-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula V 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, N-methylamido, 

N-methyl-N-tertbutylamido, 2-methylphenyl, 2-isopropylphenyl, 
2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 3-butenyl, 
2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
sec-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 2-cyclohexylethyl, 

1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl,  
 

1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 
1,1-difluoropentyl, phenyl, benzyl, 2-phenylethyl, 

1,1-difluoro-3-phenylpropyl, cyclohexylmethyl, 
cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 

2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 
2,6-difluorophenyl, 1-butenyl, 2-butenyl, 3-butenyl, 

1-butynyl, 2-butynyl, 3-butynyl, propylthio and 
butylthio; wherein R
5
 is an acidic group selected from CO
2
H 
and 


 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof. 
A compound of Claim 7 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid;  

 
3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinecarboxylic 
acid; 
3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinecarboxylic 

acid; 
5-[3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole;  

 
5-[3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-4-pyridinyl]-1H-tetrazole; 
5-[3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-l-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole; 
and 
5-[3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-4-pyridinyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula VI 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl,  
 

neopentyl, phenyl, benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, 
N-methylamido, N-methyl-N-tertbutylamido, 

2-methylphenyl, 2-isopropylphenyl, 2-methoxyphenyl, 
2-chlorophenyl, 2,6-difluorophenyl, cyclohexyl, 

cyclohexylmethyl, 2-butenyl, 3-butenyl, 2-butynyl, 
3-butynyl and 2-hydroxybutyl; wherein R
2
 is selected from 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

4-methylbutyl, n-pentyl, 1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 
1,1-difluoro-2-phenylethyl, 1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 
1,1-dimethoxybutyl, 1,1-difluoroethyl, 

1,1-difluoropropyl, 1,1-difluorobutyl, 1,1-difluoropentyl, 
phenyl, benzyl, 2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof. 
A compound of Claim 9 selected from 

compounds and their pharmaceutically-acceptable salts of 
the group of compounds consisting of 


4-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid;  

 
4-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-y1)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinecarboxylic 
acid; 
4-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
4-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinecarboxylic 

acid; 
5-[4-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole;  

 
5-[4-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-3-pyridinyl]-1H-tetrazole; 
5-[4-[4-[[3-(2-cyclohexylethyl)-5-butyl-4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
5-[4-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole; 
and 
5-[4-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-3-pyridinyl]
-1H-tetrazole. 
A compound selected from a family 
of compounds of Formula VII 


 
   wherein R
1
 is selected from methyl, 
ethyl, n-propyl, isopropyl, n-butyl, see-butyl, isobutyl, 

tert-butyl, 4-methylbutyl, n-pentyl, neopentyl, phenyl, 
benzyl, phenethyl, 2-ethylbutyl, 1,1-difluorobutyl, 

N-methylamido, N-methyl-N-tertbutylamido, 2-methylphenyl, 
2-isopropylphenyl, 2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 

cyclohexyl, cyclohexylmethyl, 2-butenyl, 
3-butenyl, 2-butynyl, 3-butynyl and 2-hydroxybutyl; wherein 

R
2
 is selected from ethyl, n-propyl, isopropyl, n-butyl, 
see-butyl, isobutyl, 4-methylbutyl, 2-ethylbutyl, n-pentyl, 

1-oxo-2-phenylethyl, 1-oxo-2-cyclohexylethyl, 1,1-difluoro-2-phenylethyl, 
1,1-difluoro-2-cyclohexylethyl, 

2-cyclohexylethyl, 1,1-difluoro-3-cyclohexylpropyl, 1,1-dimethoxybutyl, 
1,1-difluoroethyl, 1,1-difluoropropyl, 1,1-difluorobutyl, 

1,1-difluoropentyl, phenyl, benzyl, 
2-phenylethyl, 1,1-difluoro-3-phenylpropyl, 

cyclohexylmethyl, cyclohexanoyl, N-methylamido, N-methyl-N-tertbutylamido, 
2-methylphenyl, 2-isopropylphenyl, 

2-methoxyphenyl, 2-chlorophenyl, 2,6-difluorophenyl, 
1-butenyl, 2-butenyl, 3-butenyl, 1-butynyl, 2-butynyl, 

3-butynyl, propylthio and butylthio; wherein R
5
 is an 
acidic group selected from CO
2
H and 

 
or a tautomer thereof or a pharmaceutically-acceptable salt 

thereof.  
 
A compound of Claim 11 selected from 
compounds and their pharmaceutically-acceptable salts of 

the group of compounds consisting of 

3-[4-[(3-methyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 

acid; 
3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinecarboxylic 
acid; 
3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid;  
 
3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic- 

acid; 
3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinecarboxylic 

acid; 
5-[3-[4-[(3-methyl-5-buryl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-ethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-propyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopropyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-secbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isobutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-tertbutyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-pentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-isopentyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-cyclohexylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[(3-phenylmethyl-5-butyl-1H-1,2,4-triazol-1-yl)methyl]phenyl]
-2-pyridinyl]-1H-tetrazole; 
5-[3-[4-[[3-(2-cyclohexylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole;  
 
5-[3-[4-[[3-(2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxo-2-phenylethyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1-oxobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
5-[3-[4-[[3-(1,1-difluorobutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole; 
and 
5-[3-[4-[[3-(1,1-dimethoxybutyl)-5-butyl-1H-1,2,4-triazol-1-yl]methyl]
phenyl]-2-pyridinyl]
-1H-tetrazole. 
Compound of Claim 2 which is 5-[2-[6-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]-3-pyridinyl]
phenyl-lH-tetrazole 
or a pharmaceutically-acceptable 

salt thereof. 
Compound of Claim 4 which is 
5-[2-[5-[(3,5-dibutyl-1H-1,2,4-triazol-1-yl)methyl]
-2-pyridinyl]phenyl]
-1H-tetrazole 
or a pharmaceutically-acceptable salt thereof. 
Compound of Claim 4 which is 
5-[2-[5-[[3-butyl-5-(N-methyl-N-tertbutylamido)-1H-1,2,4-triazol-1-yl]
methyl]-2-pyridinyl]
phenyl]-1H-tetrazole 

or a pharmaceutically-acceptable salt thereof. 
Compound of Claim 12 which is 
5-[2-[5-[[3-(2-chlorophenyl)-5-butyl-1H-1,2,4-triazol-1-yl]
methyl]-2-pyridinyl]
phenyl]-1H-tetrazole 

or a pharmaceutically-acceptable salt thereof.  
 
A process for preparing a pharmaceutical composition 
characterized in that a therapeutically-effective amount of an 

angiontensin II antagonist compound and a pharmaceutically-acceptable 
carrier or diluent are admixed said antagonist 

copmound selected from a family of compounds according to any 
of Claim 1-16. 
Use of a compound according to any of Claims 1-16 
for preparing a medicament for treating a circulatory disorder. 
Use according to Claim 18 wherein said circulatory 
disorder is a cardiovascular disorder. 
Use according to Claim 19 wherein said cardiovascular 
disorder is hypertension. 
Use according to Claim 19 wherein said cardiovascular 
disorder is congestive heart failure. 
</CLAIMS>
</TEXT>
</DOC>
